fbpx

Investors

Opyl is headquartered in Melbourne, Australia and listed on the Australian Stock Exchange (ASX:OPL)

ASX Announcements

Opyl Appoints Global Clinical Trials And Health Tech Expert, Dr. Hugo Stephenson, As Board Advisor

download

Successful Placement of Shortfall Shares From Rights Issue

download

Opyl Rights Issue Results

download

Resignation of Director – Dr Julian Chick

download

Notice of initial substantial holder – 13 Feb 2023

download

Opyl enters into MSA and new clinical trial recruitment

download

Investor Presentations

AGM 2022 Presentation

download

AGM 2021 Presentation

download

Investor Update August 2021 Presentation

download

Investors Update May 2021 Morgans Business Breakfast

download

Half Year 2021 Presentation

download

AGM 2020 Presentation

download

Quarterly Reports

Opyl Appendix 4C – Quarter 3 (Q3) ending 31 March 2023

download

Opyl Appendix 4D – Half-year ending 31 December 2022

download

Opyl Appendix 4C – Quarter 2 (Q2) ending 31 December 2022

download

Opyl Appendix 4C – Quarter (Q1) ending 30 September 2022

download

Opyl Appendix 4C – Quarter (Q4) ending 30 June 2022

download

Opyl Appendix 4C – Quarter (Q3) ending 31 March 2022

download

Annual Reports

Opyl 2022 Annual Report

download

Opyl 2021 Annual Report

download

Opyl 2020 Annual Report

download

Corporate Governance

Opyl – Corporate Governance Statement 2022

download

Opyl – Constitution 2022

download

Opyl – Audit and Risk Committee Charter 2020

download

Opyl – Board Charter 2020

download

Opyl – Code of Conduct 2020

download

Opyl – Diversity Policy 2020

download

Opyl – Remuneration and Nomination Committee Charter 2020

download

Opyl – Trading Policy 2020

download

Opyl – Whistleblower 2020

download

Opyl – Disclosure and Communication Policy 2020

download

Opyl – Appendix 4G

download

Board and Management Team

Mark Ziirsen

Chairman

Michelle Gallaher

Chief Executive Officer

Damon Rasheed

Executive Director

Dr Megan Robertson

Non Executive Director

David Iilja

Company Secretary

Subscribe to our newsletter